TY  - RPRT
TI  - Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.
AU  - S Mani
AU  - S Goel
AU  - M Nesterova
AU  - R M Martin
AU  - J M Grindel
AU  - M L Rothenberg
AU  - R Zhang
AU  - G Tortora
AU  - Y S Cho-Chung
PY  - 2003
DO  - 10.1196/annals.1281.028
UR  - https://pubmed.ncbi.nlm.nih.gov/14751840/
ID  - 14751840
ER  -